Lund, Sweden - 12 April 2019 - Dignitana AB hereby publishes the annual report for 2018. The Annual Report is attached to this press release and will be posted today on the Dignitana website. You can also order a printed version via email@example.com.
Note: This report is published in Swedish. For a similar report in English, view the Dignitana 2018 Year End Report that was released 26 February 2019.
The above is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 8:00 CET 12 April 2019.
William Cronin, Chief Executive Officer, Dignitana AB firstname.lastname@example.org +1 469 917 5555
Mikael Wahlgren, Deputy Managing Director, Dignitana AB email@example.com +46 709 33 72 20
About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.
Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.
10925 Estate Lane, Suite 185
Dallas, TX 75238
226 60 Lund, Sweden
+46 46 16 30 90